Françoise Kraeber-Bodéré was particularly involved in the last ten years in the design of translational research programs and multicenter clinical trials evaluating innovative radiopharmaceuticals in oncology in close collaboration with industrial partners and cooperative groups. These trials have demonstrated the clinical benefits of radioimmunotherapy in lymphoma, leading in 2009 to a "Victoires de la médecine" in oncology.